PTC Therapeutics Stock Forecast
Stronger technical forecast for PTC Therapeutics stock price after Friday trading.
(Updated on Apr 19, 2024)
The PTC Therapeutics stock price gained 2.55% on the last trading day (Friday, 19th Apr 2024), rising from $24.69 to $25.32. During the last trading day the stock fluctuated 6.41% from a day low at $24.01 to a day high of $25.55. The price has fallen in 7 of the last 10 days and is down by -6.29% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 3 million more shares were traded than the day before. In total, 4 million shares were bought and sold for approximately $99.55 million.
The stock lies in the lower part of a very wide and weak rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $24.71 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 4.20% during the next 3 months and, with a 90% probability hold a price between $25.75 and $34.04 at the end of this 3-month period.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
PTCT Signals & Forecast
A buy signal was issued from a pivot bottom point on Thursday, April 18, 2024, and so far it has risen 2.55%. Further rise is indicated until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. The PTC Therapeutics stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $25.71 and $28.70. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).
Support, Risk & Stop-loss for PTC Therapeutics stock
PTC Therapeutics finds support from accumulated volume at $25.04 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $1.54 between high and low, or 6.41%. For the last week, the stock has had daily average volatility of 4.50%.
Our recommended stop-loss: $23.95 (-5.43%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 1 day ago.)
Trading Expectations (PTCT) For The Upcoming Trading Day Of Monday 22nd
For the upcoming trading day on Monday, 22nd we expect PTC Therapeutics to open at $24.96, and during the day (based on 14 day Average True Range), to move between $23.98 and $26.66, which gives a possible trading interval of +/-$1.34 (+/-5.29%) up or down from last closing price. If PTC Therapeutics takes out the full calculated possible swing range there will be an estimated 10.58% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $25.04 (1.11%) than the resistance at $27.05 (6.83%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Earnings coming up
PTC Therapeutics will release earnings AMC on Thursday, April 25, 2024.The consensus among the analysts for the expected earnings (EPS) is -$1.31. We will update the financials statements for PTC Therapeutics, that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 4.69% in the first trading day after earnings release.
Is PTC Therapeutics stock A Buy?
PTC Therapeutics holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.
Current score: -0.278 Hold/Accumulate Upgraded
Predicted Opening Price for PTC Therapeutics of Monday, April 22, 2024
Fair opening price April 22, 2024 | Current price |
---|---|
$24.96 ( 1.42%) | $25.32 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for PTCT
Fibonacci Support & Resistance Levels
Level | Price | |||
---|---|---|---|---|
Resistance | R3 | 26.50 | 4.66 % | |
R2 | 25.91 | 2.34 % | ||
R1 | 25.55 | 0.90 % | ||
Current price: | 25.32 | |||
Support | S1 | 24.37 | -3.75 % | |
S2 | 24.01 | -5.18 % | ||
S3 | 23.42 | -7.50 % |
Accumulated Volume Support & Resistance Levels
Level | Price | |||
---|---|---|---|---|
Resistance | R3 | 29.55 | 16.71 % | |
R2 | 28.19 | 11.33 % | ||
R1 | 27.05 | 6.83 % | ||
Current price | 25.32 | |||
Support | S1 | 25.04 | -1.11% | |
S2 | 24.69 | -2.49% | ||
S3 | 24.15 | -4.62% |
FAQ
Click here for our free guide on how to buy PTC Therapeutics Stock.